Research Paper Volume 15, Issue 11 pp 4986—5006
Development of cancer-associated fibroblast-related gene signature for predicting the survival and immunotherapy response in lung adenocarcinoma
Figure 4. The association of CAFs-related risk signature (CAFRS) with clinicopathologic features. (A) The heatmap illustrating the correlation between CAFRS and Age, Gender, TNM stage and survival status. (B) The fraction of patients with distinct TNM stage in low- and high-risk subgroup. (C) The riskscores between stage I+II and stage III+IV subgroups. (D) The fraction of patients with distinct survival status in low- and high-risk subgroup. (E) The riskscores between alive and dead patients. (**P < 0.01, ***P < 0.001).